Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? (Q37475726)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

anti-retroviral agent

0 references

Antonella d'Arminio Monforte

16

object named as

Antonella D'Arminio Monforte

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dominique Costagliola

6

object named as

Dominique Costagliola

0 references

Schlomo Staszewski

19

object named as

Schlomo Staszewski

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

object named as

Margaret May

3

0 references

Huldrych F Günthard

object named as

Huldrych F Günthard

9

0 references

Michael John Gill

object named as

M John Gill

14

0 references

object named as

Matthias Egger

7

0 references

11

object named as

Robert Hogg

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

François Dabis

10

object named as

Francois Dabis

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

5

object named as

Michael S Saag

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Michael J Mugavero

2

object named as

Michael J Mugavero

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Andrew N Phillips

8

object named as

Andrew Phillips

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

15

object named as

Amy Justice

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

17

object named as

Fiona Lampe

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jonathan Sterne

20

object named as

Jonathan A C Sterne

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Antiretroviral Therapy Cohort Collaboration

1

object named as

Antiretroviral Therapy Cohort Collaboration (ART-CC)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Ross Harris

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Frank de Wolf

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Gerd Fatkenheuer

13

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jose M Miró

18

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 November 2008

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

22

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

18

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

2481-2492

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Veterans Aging Cohort Study (VACS): Overview and description

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

23 August 2017

Commentary: we still need observational studies of drugs--they just need to be better

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

6 September 2017

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

6 September 2017

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

6 September 2017

Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

14 September 2017

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

14 September 2017

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

14 September 2017

Distribution of health care expenditures for HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

26 June 2018

Mortality and progression to AIDS after starting highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

26 June 2018

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

26 June 2018

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

26 June 2018

Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793403

2 September 2018

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confounding by indication

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Características clinicoepidemiológicas y tendencias en el tratamiento antirretroviral de una cohorte de pacientes con infección por el virus de la inmunodeficiencia humana. Cohorte PISCIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial treatment of HIV infection: randomized trials with clinical end points are still needed

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating treatment effects using observational data

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenges in using observational studies to evaluate adverse effects of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV: combination prescribed and biological outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trials or observational tribulations?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19005271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAD.0B013E328318F130

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37475726&oldid=1986237483"